focus -WSS

focus

author：comprehensive 2025-09-02 22:08:26 - browse：7486

Two people in protective equipment work in a lab. — JUAN MABROMATA/AFP via Getty Images

Biosimilars are no longer a new and untested class of medicines. Today, they provide critical treatment options across multiple therapeutic areas. Since the Biologics Price Competition and Innovation Act of 2009 created a regulatory pathway for biosimilar medicine review in the U.S., 37 biosimilars have come to market offering the potential to increase patient choice and cost savings. And according to the 2023 analysis from IQVIA, biosimilars are expected to generate $181 billion in savings for the U.S. health care system over the next five years.

This progress is due, in part, to thoughtfully considered, scientifically robust regulatory standards, which have instilled confidence among health care providers and patients while protecting safety. As a former associate director of therapeutic biologics at the Food and Drug Administration, I had the privilege of helping create and lead implementation of the regulatory framework for biosimilars. The FDA took great care to apply appropriate scientific rigor to the development and approval standards. While I have since moved to Amgen, my goals have remained focused on biosimilar product quality and efficacy, patient safety, and prescriber confidence.

More than a decade later, collective efforts by biosimilar manufacturers and the FDA are paying off.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： CDC launches VaccineFinder tool to locate Covid

Wikipedia

WSS

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

More regulation could be coming for drug ads

Why medical students are struggling with mental health

‘The Bear’ and hospitality in hospitals

FDA's Woodcock to retire early next year

‘The Bear’ and hospitality in hospitals

focus

focus

hotspot

Wildfire smoke exposes gaps in outdoor worker protections

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Does good food count as health care? Study aims to find out

Moonlake's readout produced a cash windfall. Risks remain

Ohioans vote in high

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Wegovy, Zepbound and weight loss drugs that preserve muscle

Anesthesiologist group: stop taking Ozempic before surgery

Travel bans should be based on evidence, not politics or fear

focus

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Germany receives 178 compensation applications from gay servicepeople over discrimination

PBM reforms clear House panel

Weight loss drug costs may need more research, senator suggests

An Ebola outbreak presents a new mystery involving children

knowledge

Wikipedia

Wikipedia

hotspot